• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性转甲状腺素蛋白淀粉样变性相关多神经病患者的临床三维步态评估

Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis.

作者信息

Vilas-Boas Maria do Carmo, Rocha Ana Patrícia, Cardoso Márcio Neves, Fernandes José Maria, Coelho Teresa, Cunha João Paulo Silva

机构信息

INESC TEC, FEUP and LABIOMEP, University of Porto, Porto, Portugal.

Unidade Corino de Andrade and Neurophysiology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal.

出版信息

Front Neurol. 2020 Nov 23;11:605282. doi: 10.3389/fneur.2020.605282. eCollection 2020.

DOI:10.3389/fneur.2020.605282
PMID:33329366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7719818/
Abstract

Hereditary amyloidosis associated with transthyretin V30M (ATTRv V30M) is a rare and inherited multisystemic disease, with a variable presentation and a challenging diagnosis, follow-up and treatment. This condition entails a definitive and progressive motor impairment that compromises walking ability from near onset. The detection of the latter is key for the disease's diagnosis. The aim of this work is to perform quantitative 3-D gait analysis in ATTRv V30M patients, at different disease stages, and explore the potential of the obtained gait information for supporting early diagnosis and/or stage distinction during follow-up. Sixty-six subjects (25 healthy controls, 14 asymptomatic ATTRv V30M carriers, and 27 symptomatic patients) were included in this case-control study. All subjects were asked to walk back and forth for 2 min, in front of a Kinect v2 camera prepared for body motion tracking. We then used our own software to extract gait-related parameters from the camera's 3-D body data. For each parameter, the main subject groups and symptomatic patient subgroups were statistically compared. Most of the explored gait parameters can potentially be used to distinguish between the considered group pairs. Despite of statistically significant differences being found, most of them were undetected to the naked eye. Our Kinect camera-based system is easy to use in clinical settings and provides quantitative gait information that can be useful for supporting clinical assessment during ATTRv V30M onset detection and follow-up, as well as developing more objective and fine-grained rating scales to further support the clinical decisions.

摘要

与转甲状腺素蛋白V30M(ATTRv V30M)相关的遗传性淀粉样变性是一种罕见的遗传性多系统疾病,表现多样,诊断、随访及治疗颇具挑战性。这种疾病会导致明确且进行性的运动功能障碍,发病初期即会影响行走能力。对后者的检测是疾病诊断的关键。本研究的目的是对处于不同疾病阶段的ATTRv V30M患者进行三维步态定量分析,并探索所获步态信息在支持早期诊断和/或随访期间疾病分期方面的潜力。本病例对照研究纳入了66名受试者(25名健康对照者、14名无症状ATTRv V30M携带者和27名有症状患者)。所有受试者被要求在为人体运动跟踪准备好的Kinect v2摄像头前前后行走2分钟。然后我们使用自己开发的软件从摄像头的三维人体数据中提取与步态相关的参数。对每个参数,对主要受试者组和有症状患者亚组进行了统计学比较。大多数所探索的步态参数有可能用于区分所考虑的组对。尽管发现了统计学上的显著差异,但其中大多数差异肉眼难以察觉。我们基于Kinect摄像头的系统在临床环境中易于使用,可提供定量的步态信息,这对于在ATTRv V30M发病检测和随访期间支持临床评估,以及制定更客观、更精细的评分量表以进一步支持临床决策可能有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/960c9869732c/fneur-11-605282-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/50665893d414/fneur-11-605282-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/dcca5cd9cb22/fneur-11-605282-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/960c9869732c/fneur-11-605282-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/50665893d414/fneur-11-605282-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/dcca5cd9cb22/fneur-11-605282-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd17/7719818/960c9869732c/fneur-11-605282-g0003.jpg

相似文献

1
Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis.遗传性转甲状腺素蛋白淀粉样变性相关多神经病患者的临床三维步态评估
Front Neurol. 2020 Nov 23;11:605282. doi: 10.3389/fneur.2020.605282. eCollection 2020.
2
Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series.遗传性转甲状腺素蛋白相关淀粉样变性患者的步态特征与分析:病例系列
J Clin Med. 2022 Jul 7;11(14):3967. doi: 10.3390/jcm11143967.
3
Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.迟发性遗传性转甲状腺素淀粉样变性多发性神经病:THAOS 登记处巴西受试者的特征。
J Neurol Sci. 2019 Aug 15;403:1-6. doi: 10.1016/j.jns.2019.05.030. Epub 2019 May 28.
4
Supporting the Assessment of Hereditary Transthyretin Amyloidosis Patients Based On 3-D Gait Analysis and Machine Learning.基于 3-D 步态分析和机器学习支持遗传性转甲状腺素蛋白淀粉样变性患者的评估。
IEEE Trans Neural Syst Rehabil Eng. 2021;29:1350-1362. doi: 10.1109/TNSRE.2021.3096433. Epub 2021 Jul 20.
5
Corrigendum: Clinical 3-D gait assessment of patients with polyneuropathy associated with hereditary transthyretin amyloidosis.勘误:遗传性转甲状腺素蛋白淀粉样变性相关多发性神经病患者的临床三维步态评估。
Front Neurol. 2022 Aug 17;13:980597. doi: 10.3389/fneur.2022.980597. eCollection 2022.
6
Unique Phenotypes With Corresponding Pathology in Late-Onset Hereditary Transthyretin Amyloidosis of A97S vs. V30M.A97S与V30M型晚发性遗传性转甲状腺素蛋白淀粉样变性中具有相应病理学特征的独特表型
Front Aging Neurosci. 2022 Jan 26;13:786322. doi: 10.3389/fnagi.2021.786322. eCollection 2021.
7
The first Transthyretin Familial Amyloid Polyneuropathy gait quantification study - preliminary results.首个转甲状腺素蛋白家族性淀粉样多神经病步态量化研究——初步结果。
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:1368-1371. doi: 10.1109/EMBC.2017.8037087.
8
Cerebellar and Cerebral Amyloid Visualized by [F]flutemetamol PET in Long-Term Hereditary V30M () Transthyretin Amyloidosis Survivors.长期遗传性V30M()转甲状腺素蛋白淀粉样变性幸存者中,[F]氟美他莫PET显像的小脑和脑淀粉样变
Front Neurol. 2022 Mar 4;13:816636. doi: 10.3389/fneur.2022.816636. eCollection 2022.
9
Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis.超越 Val30Met 转甲状腺素蛋白(TTR):与遗传性 ATTRv 淀粉样变性发病年龄相关的变异体。
Amyloid. 2021 Jun;28(2):100-106. doi: 10.1080/13506129.2020.1857236. Epub 2021 Jan 18.
10
Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients.遗传性转甲状腺素蛋白淀粉样变性中的肾脏受累:103例患者的队列研究
Clin Kidney J. 2022 May 5;15(9):1747-1754. doi: 10.1093/ckj/sfac118. eCollection 2022 Sep.

引用本文的文献

1
Slowing down in PNP: relationship of joint velocities in an arm-movement test and the fast TUG test.小儿神经心理学中的速度减缓:手臂运动测试和快速定时起立行走测试中关节速度的关系。
Sci Rep. 2025 Aug 21;15(1):30808. doi: 10.1038/s41598-025-14463-5.
2
Mexican position paper for the diagnosis and treatment of cardiac amyloidosis.墨西哥心脏淀粉样变性诊断和治疗立场文件
Arch Cardiol Mex. 2024;94(Supl 3):1-33. doi: 10.24875/ACM.M24000097.
3
Gait abnormalities in older adults with transthyretin cardiac amyloidosis.老年转甲状腺素蛋白心脏淀粉样变患者的步态异常。

本文引用的文献

1
TTR-FAP Progression Evaluation Based on Gait Analysis Using a Single RGB-D Camera.基于使用单个RGB-D相机的步态分析的转甲状腺素蛋白淀粉样变性多发性神经病(TTR-FAP)进展评估
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:5494-5497. doi: 10.1109/EMBC.2019.8857354.
2
Validation of a Single RGB-D Camera for Gait Assessment of Polyneuropathy Patients.基于单 RGB-D 相机的步态评估在多发性神经病患者中的验证。
Sensors (Basel). 2019 Nov 12;19(22):4929. doi: 10.3390/s19224929.
3
Predictive model of response to tafamidis in hereditary ATTR polyneuropathy.
Amyloid. 2024 Jun;31(2):116-123. doi: 10.1080/13506129.2024.2319133. Epub 2024 Mar 3.
4
Gait Characterization and Analysis of Hereditary Amyloidosis Associated with Transthyretin Patients: A Case Series.遗传性转甲状腺素蛋白相关淀粉样变性患者的步态特征与分析:病例系列
J Clin Med. 2022 Jul 7;11(14):3967. doi: 10.3390/jcm11143967.
5
Healthcare applications of single camera markerless motion capture: a scoping review.单摄像机无标记运动捕捉在医疗保健中的应用:范围综述。
PeerJ. 2022 May 26;10:e13517. doi: 10.7717/peerj.13517. eCollection 2022.
遗传性转甲状腺素蛋白淀粉样变性多发性神经病对塔法米迪治疗反应的预测模型。
JCI Insight. 2019 Jun 20;4(12). doi: 10.1172/jci.insight.126526.
4
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.遗传性转甲状腺素蛋白淀粉样变性病:致命疾病的医学进步典范。
Nat Rev Neurol. 2019 Jul;15(7):387-404. doi: 10.1038/s41582-019-0210-4. Epub 2019 Jun 17.
5
Three-dimensional cameras and skeleton pose tracking for physical function assessment: A review of uses, validity, current developments and Kinect alternatives.用于身体功能评估的三维相机和骨骼姿势跟踪:用途、有效性、当前进展及Kinect替代方案综述
Gait Posture. 2019 Feb;68:193-200. doi: 10.1016/j.gaitpost.2018.11.029. Epub 2018 Nov 22.
6
Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study.葡萄牙转甲状腺素蛋白家族性淀粉样多发性神经病的流行病学:一项全国性研究。
Neuroepidemiology. 2018;51(3-4):177-182. doi: 10.1159/000490553. Epub 2018 Aug 28.
7
System for automatic gait analysis based on a single RGB-D camera.基于单目 RGB-D 相机的自动步态分析系统。
PLoS One. 2018 Aug 3;13(8):e0201728. doi: 10.1371/journal.pone.0201728. eCollection 2018.
8
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.依洛瑟那治疗遗传性转甲状腺素蛋白淀粉样变性病患者。
N Engl J Med. 2018 Jul 5;379(1):22-31. doi: 10.1056/NEJMoa1716793.
9
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.用于遗传性转甲状腺素蛋白淀粉样变性的 RNAi 治疗药物 Patisiran
N Engl J Med. 2018 Jul 5;379(1):11-21. doi: 10.1056/NEJMoa1716153.
10
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.转甲状腺素蛋白家族性淀粉样多发性神经病(TTR-FAP):早期诊断的参数。
Brain Behav. 2017 Dec 19;8(1):e00889. doi: 10.1002/brb3.889. eCollection 2018 Jan.